Use of a pediatric end-stage liver disease score for deceased donor allocation: The United States experience

Indian Journal of Pediatrics

Volumn 74, Issue 4, 2007, Pages 387-392

  McDiarmid, Sue V ^a,d   Merion, Robert M ^b,c   Dykstra, Dawn M ^b,c   Harper, Ann M ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Univ Ren Res and Educ Assoc   (United States)

^c Departments of Research and Allocation Policy   (United States)

^d UCLA MEDICAL CENTER   (United States)

Author keywords

Mortality; Pediatric; Score; Transplant

Indexed keywords

BILIRUBIN; SERUM ALBUMIN;

BILIRUBIN BLOOD LEVEL; CHRONIC LIVER DISEASE; CONFERENCE PAPER; DISEASE SEVERITY; GROWTH DISORDER; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER GRAFT; MORTALITY; MULTIVARIATE ANALYSIS; ORGAN DONOR; PEDIATRIC END STAGE LIVER DISEASE SCORE; PREDICTION; RATING SCALE; ARTICLE; CADAVER; CHILD; CHRONIC DISEASE; CLASSIFICATION; DONOR; HEALTH CARE ORGANIZATION; HOSPITALIZATION; LIVER FAILURE; LIVER TRANSPLANTATION; ORGANIZATION AND MANAGEMENT; TRANSPLANTATION; UNITED STATES;

CADAVER; CHILD; CHRONIC DISEASE; HEALTH CARE RATIONING; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; SEVERITY OF ILLNESS INDEX; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; UNITED STATES; WAITING LISTS;

EID: 34248177221     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-007-0066-2     Document Type: Conference Paper

References (14)

1. Wiesner RH, McDiarmid SV, Kamath PS, Edward EB, Malinchoc M, Kremers WK et al. Meld and Peld: Application of Survival Models to Liver Allocation. Liver Transplantation 2001; 7: 567-80.
2. Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards, E et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transplantation 2002; 8(9): 851-858.
3. McDiarmid SV, Anand R, And Lindblad A. Development of a pediatric end stage liver disease score to predict poor outcome awaiting liver transplantation. Transplantation 2002
4. Mazariegos, G. V., Anand, R., and McDiarmid, S. V. Validation of PELD Severity Score in a Pediatric Transplant Candidate Database. Amer J Transplantation 2002; 2(3): 251.
5. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
6. SPLIT Research Group. Studies of Pediatric Liver Transplantation (SPLIT): Year 2000 Outcomes. Transplantation 2001; 72: 463-476.
7. McDiarmid, S. New liver allocation policies and their potential effect on pediatric patients awaiting liver transplantation. Pediatric Transplantation 2002; 6: 180-186.
8. HHS/HRSA/OSP/DOT, UNOS, and URREA. 2002 OPTN/SRTR Annual Report 1992-2001. 2002.
9. McDiarmid, SV, Harper AM. Are too many pediatric liver recipients transplanted at status 1? Amer J Transplantation 4[Suppl 8]. 2004.
10. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, and Wolfe R. Results of the first year of the new liver allocation plan. Liver Transplantation 2004; 10(1): 7-15.
11. Organ Procument and Transplantation Network-HRSA. Final Rule with comment period. Federal Register 1998; 63: 16296-16338.
12. Olthoff KM, Brown R, Delmonico F, Freeman R, McDiarmid S, Merion, et al. Evolving concepts in liver allocation in the MELD/PELD era: Summary Report of a National Conference. Liver Transplantation 2004
13. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe, RA. The survival benefit of liver transplantation. Amer Soc Transplant Physicians 4[Suppl 8]: 2004.
14. McDiarmid SV, Gornbein JA, DeSilva P, Goss JA, Vargas JH, Martin MG et al. Factors affecting growth after pediatric liver transplantation. Transplantation 1999; 67: 404-411.